Microarray Market Rapidly Growing in Healthcare, Competitor Analysis, Complete Study of Current Trends and Forecast 2016-2027
The
North America Microarray Market is growing with the rapid pace; mainly due to
the technological advancement. According
to a recent study report published by the Market Research Future, The North America
Microarray market has been booming and expected to gain prominence over the forecasting period.
The market is forecasted to demonstrate a spectacular growth by 2027,
surpassing its previous growth records in terms of value with a striking CAGR
during 2016 – 2027. The North America Microarray market is expected to
reach USD 1,635.4 billion by 2027 with a CAGR of 4% during 2016 to 2027.
North
America’s Microarray Market is predominantly driven by the technological
advancements. Additionally, factors such as improved healthcare infrastructure,
increasing research and development activities, usage of personalized
medicines, government initiatives and rise in the incidences of cancer are
fostering the market growth up to large extent.
Moreover,
increasing government spending, rise in research and development activities,
need for early cancer detection, increasing healthcare expenditure, and diagnosis
and large-scale DNA/gene chip initiatives are expected to drive the North
America market for microarrays during the forecast period. In addition,
adoption of personalized medicines, wide range of application areas, and
technological advancements are expected to drive the market for microarrays.
Standardization
in microarray data and lack of skilled professionals are some of the major
factors anticipated to challenge the growth of the North America’s Microarrays
market.
North America the
market for Microarray is increasing rapidly. A Microarray is a multiplex
lab-on-a-chip. It is a 2D array on a solid substrate, usually a glass slide or
silicon thin-film cell, that assays large amounts of biological material using
high-throughput screening miniaturized, multiplexed and parallel processing and
detection methods. Globally the Microarray market is dominated by DNA
Microarrays. The protein Microarray is currently the fastest growing market.
The use of peptide and carbohydrate Microarrays is expanding. Tissue and cell Microarrays
are in their infancy stage and are developing slowly because of many
complications in the process development. North American market for Microarray
is expected to grow at the rate of about 4.0% from 2016 to 2027.
North America Microarray Market - Competitive Analysis
Characterized by
the presence of several well-established and small players, the North America
Market of
Microarray appears to be highly fragmented and competitive. Well
established players incorporate acquisition, collaboration, partnership,
expansion, and product launch in order to gain competitive advantage in this
market and to maintain their market position. The Key players operating in the
market compete based on pricing, availability, brand, and variety.
Manufacturers adopt modern manufacturing process to ensure safety
and convenience. Marketers employ a continuous improvement strategy
to analyze and update drugs, implementing improvements and launching
new solutions to meet the changing needs of both patients and health care
professionals. Manufacturers invest
heavily in to developing pipeline of innovative drugs to address unmet patient
needs. Investment activities in the
Microarray Market are interpreted as capacity expansion plan and intensive
R&D with an aim of obtaining vast growth opportunities.
North America Microarray Market - Segments
The Microarray Market can be segmented in to 4 key dynamics for the
convenience of the report and enhanced understanding;
Segmentation By
Type : Comprises Protein
Microarray, Tissue Microarray, and Cellular Microarray.
Segmentation By
Product : Comprises Paraffin
Tissue Sections (FFPE), Frozen Tissue Sections and other
Segmentation By Application : Comprises
Immunohistochemistry, In-Situ Hybridization.
Segmentation By
Regions
: Comprises
Geographical regions and countries of - North America such as US, Canada etc.
Paraffin tissue sections (FFPE) hold the largest share of 54.6% of the North America Tissue Microarray market.
Immunohistochemistry
segment holds the largest market share of 47.5% in 2015.
North America Microarray Market - Regional Analysis
In North America,
U.S. is the largest market for Tissue Microarray. Canada is the second-largest
market and is expected to be fastest growing market for Tissue Microarray in
North America.
U.S. holds the
largest market share of North America Tissue Microarray market and is
anticipated to reach $364.2 million by the end of 2027.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various
industries through our Cooked Research Report (CRR), Half-Cooked Research
Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and
Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality
market research and intelligence services to our clients. Our market research
studies by products, services, technologies, applications, end users, and
market players for global, regional, and country level market segments, enable
our clients to see more, know more, and do more, which help to answer all their
most important questions.
In order to stay updated with technology and work process of the
industry, MRFR often plans & conducts meet with the industry experts and
industrial visits for its research analyst members.
Contact
Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Comments
Post a Comment